Bone Loss After Romosozumab/Denosumab: Effects of Bisphosphonates. [electronic resource]
Producer: 20190716Description: 55-61 p. digitalISSN:- 1432-0827
- Aged
- Antibodies, Monoclonal -- administration & dosage
- Bone Density -- drug effects
- Bone Density Conservation Agents -- therapeutic use
- Bone Remodeling -- drug effects
- Clinical Trials, Phase III as Topic
- Denosumab -- administration & dosage
- Diphosphonates -- administration & dosage
- Female
- Humans
- Middle Aged
- Osteoporosis, Postmenopausal -- drug therapy
- Randomized Controlled Trials as Topic
- Risedronic Acid -- administration & dosage
- Zoledronic Acid -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.